EP3509637
METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.9.2017EP published:
27.11.2024EP application number:
17848753.4
EPO information:
European Patent Register
Max expiry date:
4.9.2037
Title in English:
METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR XLanguage of the patent:
English
Timeline
Today
5.9.2017EP application
27.11.2024EP Publication
Owner
Name:
Chugai Seiyaku Kabushiki KaishaAddress:
5-1, Ukima 5-chome, Kita-ku Tokyo 115-8543, JP
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
YONEYAMA, KoichiroAddress:
Tokyo 103-8324, JP
Name:
SCHMITT, ChristopheAddress:
4070 Basel, CH
Priority
Number:
201662383933 PDate:
6.9.2016Country:
US
Number:
201662437281 PDate:
21.12.2016Country:
US
Number:
201762485514 PDate:
14.4.2017Country:
US
Classification
Categories:
A61K 39/395, A61P 7/04